SCHEMBL118953

SCHEMBL118953

CCOC(=O)c1cn2c(C)ccc(Br)c2n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.59
CYP1A2 P05177 1/20 0.46
KDM4E B2RXH2 3/20 0.45
POLB P06746 2/20 0.45
EED O75530 1/20 0.45
RBBP4 Q09028 1/20 0.45
SUZ12 Q15022 1/20 0.45
EZH2 Q15910 1/20 0.45
AEBP2 Q6ZN18 1/20 0.45
NPC1 O15118 2/20 0.44
RAB9A P51151 2/20 0.44
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GABRA2 P47869 5/20 0.44
GABRB2 P47870 5/20 0.44
ADORA2A P29274 1/20 0.43
MAPT P10636 1/20 0.43
PKM P14618 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7269769 0.86 GAA (0.62) GAACYP1A2KDM4EPOLBNPC1
SCHEMBL8607646 0.78 GAA (0.53) GAACYP1A2KDM4EPOLBNPC1
SCHEMBL117700 0.78 KDM4E (0.58) GAACYP1A2KDM4EPOLBNPC1
SCHEMBL117177 0.78 GAA (0.63) GAACYP1A2KDM4EPOLBNPC1
SCHEMBL22750046 0.77 EED (0.49) GAACYP1A2KDM4EPOLBEED
SCHEMBL21236325 0.77 GAA (0.46) GAACYP1A2KDM4EPOLBEED
SCHEMBL101291 0.74 GAA (1.00) GAACYP1A2KDM4EPOLBNPC1
SCHEMBL31244505 0.73 GAA (0.50) GAACYP1A2KDM4EPOLBRAB9A
SCHEMBL31211064 0.72 GAA (0.52) GAACYP1A2KDM4EPOLBNPC1
SCHEMBL24737463 0.72 KDM4E (0.54) GAACYP1A2KDM4EPOLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424866-A1 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS -SECRETASE INHIBITORS High Point Pharmaceuticals, LLC (US) 2012-03-07 EP disclosed
WO-2010126745-A1 SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE AS β-SECRETASE INHIBITORS HIGH POINT PHARMACEUTICALS, LLC (US) 2010-11-04 WO disclosed
US-5716964-A BRAIN DISORDERS; ANTIISCHEMIC AGENTS G.D. SEARLE & CO. (US) 1998-02-10 US disclosed
EP-0436831-A2 Imidazo[1,2-a]pyridinylalkyl compounds for treatment of neurotoxic injury G.D. Searle & Co. (US) 1991-07-17 EP disclosed